KS

Kirti Surendra Harde

Active Director Director DIN 08243425
DIN 08243425 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Kirti Surendra Harde

Data last updated:

Kirti Surendra Harde is a Director at Gressmed Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Gressmed Pharmaceutical Private Limited reported revenue of ₹27.8 Lakh (FY 2022).

DIN 08243425
Primary Designation Director
Industry Pharma
First Appointment 29 Sep 2018
Oldest Company Age 8 yrs
Largest company Gressmed Pharmaceutical Private Limited · ₹27.8 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Sep 20182018₹27.8 Lakh (FY 2022)Active

Board colleagues of Kirti Surendra Harde

Directorship timeline

Open interactive timeline →
Gressmed Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Kirti Surendra Harde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kirti Surendra Harde

Kirti Surendra Harde currently holds 1 directorship: Gressmed Pharmaceutical Private Limited (Director, since 29 Sep 2018, revenue ₹27.8 Lakh (FY 2022)).

Kirti Surendra Harde was first appointed on 29 Sep 2018 as Director at Gressmed Pharmaceutical Private Limited.

The current boards of Kirti Surendra Harde's companies include Surendra Namdeorao Harde (Gressmed Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available